Edema from Taking Cinnamon for Treatment of Diabetes: Similar Biochemistry and Pathophysiology to Thiazolidinedione Medications

References

1. 1.↵
   1. Ali-Shtayeh MS,
   2. Jamous RM,
   3. Jamous RM

   . Complementary and alternative medicine use amongst Palestinian diabetic patients. Complement Ther Clin Pract 2012;18:16–21.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Manya K,
   2. Champion B,
   3. Dunning T

   . The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement Altern Med 2012;12:2.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Fabian E,
   2. Töscher S,
   3. Elmadfa I,
   4. et al

   . Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann Nutr Metab. 2011;58:101–8.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Ranasinghe P,
   2. Jayawardena R,
   3. Pigera S,
   4. et al

   . Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: A phase I clinical trial. BMC Complement Altern Med 2017;17:550.

   OpenUrl
5. 5.↵
   1. Ackermann L,
   2. Aalto-Korte K,
   3. Jolanki R,
   4. et al

   . Occupational allergic contact dermatitis from cinnamon including one case from airborne exposure. Contact Dermatitis 2009;60:96–9.

   OpenUrlPubMed
6. 6.↵
   1. Kind F,
   2. Scherer K,
   3. Bircher AJ

   . Allergic contact stomatitis to cinnamon in chewing gum mistaken as facial angioedema. Allergy 2010;65:276–7.

   OpenUrlPubMed
7. 7.↵
   1. Brancheau D,
   2. Patel B,
   3. Zughaib M

   . Do cinnamon supplements cause acute hepatitis? Amer J Case Rep 2015;16:250–4.

   OpenUrl
8. 8.↵
   1. Campbell TM,
   2. Neems R,
   3. Moore J

   . Severe exacerbation of rosacea induced by cinnamon supplements. J Drugs Dermatol 2008;7:586–7.

   OpenUrlPubMed
9. 9.↵
   Clincalc. Pioglitazone hydrochloride. Drug Usage Statistics, United States, 2005–2015. Available from: http://clincalc.com/DrugStats/Drugs/PioglitazoneHydrochloride. Accessed May 31, 2018.
10. 10.↵
    1. Horita S,
    2. Nakamura M,
    3. Satoh N,
    4. et al

    . Thiazolidinediones and edema: Recent advances in the pathogenesis of thiazolidinediones-induced renal sodium retention. PPAR Res 2015;2015:646423.

    OpenUrlPubMed
11. 11.↵
    1. Bełtowski J,
    2. Rachańczyk J,
    3. Włodarczyk M

    . Thiazolidinedione-induced fluid retention: Recent insights into the molecular mechanisms. PPAR Res 2013;2013:628628.

    OpenUrlPubMed
12. 12.↵
    1. Abbas S,
    2. Raza ST,
    3. Ahmed F,
    4. et al

    . Association of genetic polymorphism of PPARγ-2, ACE, MTHFR, FABP-2 and FTO genes in risk prediction of type 2 diabetes mellitus. J Biomed Sci 2013;201320:80.

    OpenUrl
13. 13.↵
    1. Steiner G,
    2. Hamsten A,
    3. Hosking J,
    4. et al

    . Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001;357:905–10.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Olefsky JM

    . Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 2000;106:467–72.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Hosni AA,
    2. Abdel-Moneim AA,
    3. Abdel-Reheim ES,
    4. et al

    . Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPARγ, proinflammatory cytokines and oxidative stress. Biomed Pharmacother 2017;88:52–60.

    OpenUrl
16. 16.↵
    1. Li JE,
    2. Futawaka K,
    3. Yamamoto H,
    4. et al

    . Cinnamaldehyde contributes to insulin sensitivity by activating PPARδ, PPARγ, and RXR. Amer J Chin Med 2015;43:879–92.

    OpenUrl
17. 17.↵
    1. Sheng X,
    2. Zhang Y,
    3. Gong Z,
    4. et al

    . Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res 2008;2008:581348.

    OpenUrlPubMed
18. 18.↵
    1. Kim SH,
    2. Choung SY

    . Antihyperglycemic and antihyperlipidemic action of Cinnamomi cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice. Arch Pharm Res 2010;33:325–33.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Zanchi A,
    2. Maillard M,
    3. Jornayvaz FR,
    4. et al

    . Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals. Diabetologia 2010;53:1568–75.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Alemán-González-Duhart D,
    2. Tamay-Cach F,
    3. Álvarez-Almazán S,
    4. et al

    . Current advances in the biochemical and physiological aspects of the treatment of type 2 diabetes mellitus with thiazolidinediones. PPAR Res 2016;2016:7614270.

    OpenUrl
21. 21.↵
    1. Berlie HD,
    2. Kalus JS,
    3. Jaber LA

    . Thiazolidinediones and the risk of edema: A meta-analysis. Diab Res Clin Prac 2007;76:279–89.

    OpenUrl